– KIST 선임연구원 (2015~)

– KIST 박사후 연구원. (2013-2015)

– 방문연구, 독일 Max-Planck Institute. Prof. Paul Schulze-Lefrt, (2009, 2010-2011)

– 유전자 가위를 활용한 암 및 면역 세포의 리프로그래밍을 통한 항암면역 치료 연구

– 면역치료에 응용을 위한 유전자 가위의 효율적인 전달체 개발

– 세포 리프로그래밍 기술 개발

– 자연살해세포를 이용한 항암 면역 치료 연구

– 암환자 혈액에서의 초고속 대용량 면역원성 검증법 개발

1. Seung Min Kim, Sang Chul Shin, Eunice EunKyeong Kim, Sang-Heon Kim, Kwideok Park, Seung Ja Oh*,Mihue Jang*, Simple in Vivo Gene Editing via Direct Self-Assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment. ACS NANO, 2018, * Corresponding author

2. Minkoo Seo, Jin-Chul Kim, Hyung-Ki Kim, Eun wook Choi, Suyeong Jeong, Ki Chang Nam*, Mihue Jang*, A Novel Secretory Vesicle from Deer Antlerogenic Mesenchymal Stem Cell-Conditioned Media (DaMSC-CM)Promotes Tissue Regeneration. Stem Cells International, 2018, 3891404, * Corresponding author

3. Minkoo Seo, Seung Min Kim, Eun Young Woo, Ki-Cheol Han, Eun Joo Park, Seongyeol Ko, Eun wook Choi*, Mihue Jang*, Stemness-Attenuating miR-503-3p as a Paracrine Factor to Regulate Growth of Cancer Stem Cells. Stem Cells International, 2018, 4851949, * Corresponding author

4. Seung Min Kim, Yoosoo Yang, Seung Ja Oh, Yeonsun Hong, Minkoo Seo, Mihue Jang*, Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting. Journal of Controlled Release, 2017, 266, 8-16. * Corresponding author

5. Seung Min Kim, Yoosoo Yang, Seung Ja Oh, Yeonsun Hong, Minkoo Seo, Mihue Jang*, Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting. Journal of Controlled Release, 2017, 266, 8-16. * Corresponding author